Phreesia (PHR)
(Real Time Quote from BATS)
$21.98 USD
+0.79 (3.73%)
Updated Aug 8, 2024 03:48 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PHR 21.98 +0.79(3.73%)
Will PHR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PHR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PHR
P3 Health Partners Inc. (PIII) Reports Q2 Loss, Tops Revenue Estimates
Nyxoah SA (NYXH) Reports Q2 Loss, Misses Revenue Estimates
PHR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think Phreesia (PHR) Could Surge 27.77%: Read This Before Placing a Bet
Phreesia (PHR) Upgraded to Strong Buy: Here's What You Should Know
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
Other News for PHR
Bob Glazer Joins Phreesia as Strategic Advisor
PHR Makes Notable Cross Below Critical Moving Average
Omnicell Inc's Meteoric Rise: Unpacking the 32% Surge in Just 3 Months
Phreesia Sets Release Date for Fiscal Second Quarter 2025 Results
Phreesia Now Available on Oracle Healthcare Marketplace